CONFIDENTIAL REG NO: .................... NOTICE OF TERMINATION OF METHADONE BUPRENORPHINE SUBOXONE SUBUTEX PRESCRIBING DETAILS MUST BE COMPLETED LEGIBLY TO PREVENT DELAY DEPARTMENT of HEALTH and HUMAN - Drug Addiction Treatment Act - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2011-05-25 01:48:13 Alcohols Morphinans Buprenorphine Euphoriants Phenols Methadone Drug Addiction Treatment Act Chemistry Drug rehabilitation Organic chemistry		CONFIDENTIAL REG NO: .................... NOTICE OF TERMINATION OF METHADONE/BUPRENORPHINE/SUBOXONE/SUBUTEX PRESCRIBING DETAILS MUST BE COMPLETED LEGIBLY TO PREVENT DELAY DEPARTMENT of HEALTH and HUMAN Add to Reading List Source URL: dhhs.clients.squiz.net Download Document from Source Website File Size: 40,77 KB Share Document on Facebook

	New Mexico Buprenorphine Waiver Training Helping states connect the dots to more effectively address opioid use disorders Date: August 19, 2016 DocID: 1qTe5 - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION -----------------WARNINGS AND PRECAUTIONS----------------- These highlights do not include all the information needed to use PROBUPHINE® safely and effectively. See full prescribin DocID: 1oIqx - View Document
	mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 80, NoWednesday, May 20, Notices the experience of the applicant in dispensing controlled substances is of such character and quality that DocID: 1agX5 - View Document
	The Recovery Enhancement for Addiction Treatment Act (TREAT Act) Senator Edward J. Markey (D-Mass.) Overdoses from opioids, including prescription pain relievers and heroin, have increased dramatically in the United Stat DocID: 19MI3 - View Document
	Testimony Before the U.S. Senate Caucus on International Narcotics Control Hearing on “America’s Addiction to Opioids: Heroin and Prescription Drug Abuse” May 14, 2014 Statement of H. Westley Clark, M.D., J.D., M. DocID: 19ItS - View Document